Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Immune-associated pivotal biomarkers identification and competing endogenous RNA network construction in post-operative atrial fibrillation by comprehensive bioinformatics and machine learning strategies. | Front Immunol | 2022 | 36341343 | PubTator, text mining | PubMed |
| Plasma proteomic signature of decline in gait speed and grip strength. | Aging Cell | 2022 | 36333824 | PubTator, text mining | PubMed |
| Pitfalls in complement analysis: A systematic literature review of assessing complement activation. | Front Immunol | 2022 | 36330514 | PubTator, text mining | PubMed |
| BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling. | Nat Commun | 2022 | 36316305 | PubTator, text mining | PubMed |
| Scientific Research Directions on the Histopathology and Immunohistochemistry of the Cutaneous Squamous Cell Carcinoma: A Scientometric Study. | Medicina (Kaunas) | 2022 | 36295609 | PubTator, text mining | PubMed |
| HLA-B*27 Heavy Chain Homo-Oligomers Promote the Cytotoxicity of NK Cells via Activation of PI3K/AKT Signaling. | Medicina (Kaunas) | 2022 | 36295572 | PubTator, text mining | PubMed |
| The Complement System: A Potential Therapeutic Target in Liver Cancer. | Life (Basel) | 2022 | 36294966 | PubTator, text mining | PubMed |
| Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease. | Int J Mol Sci | 2022 | 36293475 | PubTator, text mining | PubMed |
| Components of the Complement Cascade Differ in Polycystic Ovary Syndrome. | Int J Mol Sci | 2022 | 36293087 | PubTator, text mining | PubMed |
| Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. | Biomolecules | 2022 | 36291687 | PubTator, text mining | PubMed |
| No prominent role for complement C1-esterase inhibitor in Marfan syndrome mice. | Vasc Biol | 2022 | 36279189 | PubTator, text mining | PubMed |
| Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross-reactive potential. | Clin Transl Immunology | 2022 | 36275878 | PubTator, text mining | PubMed |
| Complement C1s as a diagnostic marker and therapeutic target: Progress and propective. | Front Immunol | 2022 | 36275687 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing of retrieved human oocytes and eggs in clinical practice and for human ovarian cell atlasing. | Mol Reprod Dev | 2022 | 36264989 | PubTator, text mining | PubMed |
| Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling. | Circ Genom Precis Med | 2022 | 36252118 | PubTator, text mining | PubMed |
| The role of complement in nonalcoholic fatty liver disease. | Front Immunol | 2022 | 36248852 | PubTator, text mining | PubMed |
| Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound. | J Diabetes Res | 2022 | 36248223 | PubTator, text mining | PubMed |
| A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients. | Front Genet | 2022 | 36246657 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes induced by aberrant methylation in acute myeloid leukemia using integrated bioinformatics analyses. | Oncol Lett | 2022 | 36238356 | PubTator, text mining | PubMed |
| Ehlers-Danlos syndromes and their manifestations in the visual system. | Front Med (Lausanne) | 2022 | 36237549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=23